Quad Technologies Partners With Sartorius Stedim Biotech On CD3/CD28 T Cell Activation Product
Quad Technologies, which was co-founded by ChE Professor Shashi Murthy, Sean Kevlahan (PhD ’13), Adam Hatch (PhD ’14), and Brian Plouffe (PhD ’11), was featured in BusinessWire's article "Quad Technologies Partners With Sartorius Stedim Biotech On CD3/CD28 T Cell Activation Product" announcing their new strategic partnership with global leader in bioprocess technologies, Sartorius Stedim Biotech.